Health Catalyst Inc. logo

Health Catalyst Inc.

HCAT | NASDAQ
Chart Builder DCF Calculator
$1.81
+$0.02 (+1.12%)
At close: Sep 21, 2026, 4:00 PM ET
$1.81
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$133.75M
Enterprise Value
$48.43M
Beta
1.53
Average Volume
1.31M
Shares Outstanding (Diluted)
73.96M
Shares Change YoY
6.22%
Institutional Ownership
76.91%
Exchange
NASDAQ
ISIN
US42225T1079

Price Performance

Price Change 1M
16.0%
Price Change 3M
2.8%
Price Change 6M
64.5%
Price Change YTD
-20.6%
Price Change 1Y
-38.6%
Price Change 3Y
-81.5%
Price Change 5Y
-96.6%
1M CAGR (ann.)
4.6%
1Y CAGR (ann.)
-40.1%
5Y CAGR (ann.)
-49.4%
All-Time CAGR
-34.9%

Valuation

PE Ratio
-0.49
Forward PE
37.30
PEG Ratio
0.01
Forward PEG
0.00
PS Ratio
0.46
Forward PS
0.60
PB Ratio
1.33
P/FCF Ratio
3.71
P/Adj. FCF Ratio
7.26
P/OCF Ratio
4.76
EV/Sales
0.17
EV/EBIT
-0.20
EV/EBITDA
-0.26
EV/FCF
1.34
Earnings Yield
-203.3%
FCF Yield
26.9%
Adj. FCF Yield
13.8%

Financial Health

Net Cash
$85.31M
Total Debt
$18.13M
Cash & Short-Term Investments
$103.44M
Total Assets
$358.6M
Current Ratio
2.70
Quick Ratio
2.70
Debt / Equity Ratio
1.69
Debt / EBITDA
-0.10
Debt / FCF
0.50
OCF / Debt
2.58
Interest Coverage
-2.80
Altman Z-Score
-6.55
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
46.4%
Operating Profit Margin
-19.7%
EBITDA Margin
-64.0%
Net Profit Margin
-90.6%
FCF Margin
12.3%
Adj. FCF Margin
6.3%
SBC / Revenue
6.0%
SBC Impact (per share)
-48.9%

Returns

Return on Assets
-73.8%
Return on Equity
-129.7%
Return on Invested Capital
-21.1%
Return on Capital Employed
-21.6%
Return on Tangible Assets
-90.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
0.9%
Revenue CAGR 5Y
6.2%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-48.9%
EPS CAGR 5Y
-2.4%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
2671.6%
FCF CAGR 5Y
101.8%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
22
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.02
EPS Growth Est (next Q)
-133.3%
Revenue Est (next Q)
$55.44M
Revenue Growth Est (next Q)
-27.4%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$1.77
Price Target Upside
-2.2%

Cash Flow

Operating Cash Flow
$46.75M
Free Cash Flow
$36.04M
Adj. Free Cash Flow
$18.42M
FCF Per Share
$0.18
OCF Per Share
$0.38
OCF/S Ratio
9.7%

Income Statement

Revenue
$292.25M
Gross Profit
$135.72M
Operating Income
$-57.48M
EBITDA
$-187.07M
Net Income
$-264.82M
EPS (Diluted)
-$3.68
Revenue / Employee
$243.54K
Profit / Employee
$-220.68K
Employees
1,200

© 2026 bestshares.com. All rights reserved.